Patent · US Active

Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

US11267818B2 · kind B2 · utility

0Cited by
65References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 2020
Grant dateMar 8, 2022
Priority date
Expiry dateSep 14, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.